PT2392337E - Utilização de 24-norudca - Google Patents

Utilização de 24-norudca Download PDF

Info

Publication number
PT2392337E
PT2392337E PT111762720T PT05176272T PT2392337E PT 2392337 E PT2392337 E PT 2392337E PT 111762720 T PT111762720 T PT 111762720T PT 05176272 T PT05176272 T PT 05176272T PT 2392337 E PT2392337 E PT 2392337E
Authority
PT
Portugal
Prior art keywords
norudca
Prior art date
Application number
PT111762720T
Other languages
English (en)
Inventor
Michael Trauner
Alan Hofmann
Peter Fickert
Original Assignee
Medizinische Universität Graz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinische Universität Graz filed Critical Medizinische Universität Graz
Publication of PT2392337E publication Critical patent/PT2392337E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT111762720T 2005-05-12 2005-05-12 Utilização de 24-norudca PT2392337E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/052178 WO2006119803A1 (en) 2005-05-12 2005-05-12 USE OF 24-nor-UDCA

Publications (1)

Publication Number Publication Date
PT2392337E true PT2392337E (pt) 2015-11-02

Family

ID=35457032

Family Applications (3)

Application Number Title Priority Date Filing Date
PT111762720T PT2392337E (pt) 2005-05-12 2005-05-12 Utilização de 24-norudca
PT111762712T PT2392336T (pt) 2005-05-12 2005-05-12 24-norudca para o tratamento de hepatite autoimune
PT111762704T PT2392335E (pt) 2005-05-12 2005-05-12 Utilização de 24-norudca

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT111762712T PT2392336T (pt) 2005-05-12 2005-05-12 24-norudca para o tratamento de hepatite autoimune
PT111762704T PT2392335E (pt) 2005-05-12 2005-05-12 Utilização de 24-norudca

Country Status (18)

Country Link
US (1) US8951995B2 (pt)
EP (4) EP2392335B1 (pt)
AU (1) AU2005331734B2 (pt)
CY (4) CY1116831T1 (pt)
DK (4) DK1890705T3 (pt)
EA (1) EA014077B1 (pt)
ES (4) ES2547127T3 (pt)
HK (1) HK1161122A1 (pt)
HR (3) HRP20150949T1 (pt)
HU (4) HUE025409T2 (pt)
LT (1) LT2392336T (pt)
ME (3) ME02256B (pt)
NO (1) NO340318B1 (pt)
PL (4) PL2392336T3 (pt)
PT (3) PT2392337E (pt)
RS (3) RS54140B1 (pt)
SI (4) SI1890705T1 (pt)
WO (1) WO2006119803A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
PT2182954T (pt) * 2007-07-25 2019-02-06 Univ Graz Medizinische Utilização de ácidos nor-biliares no tratamento de arteriosclerose
EP2468762A1 (en) * 2010-11-30 2012-06-27 Dr. Falk Pharma Gmbh Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
EP3461485A1 (en) 2017-09-28 2019-04-03 Dr. Falk Pharma Gmbh Use of nor-ursodeoxycholic acid for reducing liver fat
GB201911821D0 (en) 2019-08-16 2019-10-02 Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy And Undivid Compounds for use in the treatment of liver disease
US11372809B2 (en) * 2019-09-27 2022-06-28 Oracle International Corporation System and method for providing correlated content organization in an enterprise content management system based on a training set
WO2021130232A1 (en) 2019-12-23 2021-07-01 Medizinische Universität Wien Bile acid derivatives in the medical intervention of anxieties and/or stress symptoms
WO2024023669A1 (en) * 2022-07-25 2024-02-01 Shilpa Medicare Limited Pharmaceutical compositions of nor-udca

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892868A (en) 1984-08-17 1990-01-09 Gipharmex, S.P.A. Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions
IT1229569B (it) * 1989-04-17 1991-09-04 Giuliani Spa Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1255449B (it) 1992-06-30 1995-10-31 Fabio Berlati Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TW289020B (pt) 1993-05-08 1996-10-21 Hoechst Sktiengesellschaft
ITMI20012572A1 (it) 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico

Also Published As

Publication number Publication date
EP2392335A2 (en) 2011-12-07
ES2550204T3 (es) 2015-11-05
EP2392336A3 (en) 2011-12-28
RS55180B1 (sr) 2017-01-31
US20090163459A1 (en) 2009-06-25
EP2392337A3 (en) 2012-01-04
HRP20161197T1 (hr) 2016-11-04
PL2392335T3 (pl) 2015-10-30
US8951995B2 (en) 2015-02-10
SI2392336T1 (sl) 2016-10-28
EA014077B1 (ru) 2010-08-30
EP1890705B1 (en) 2015-11-11
DK1890705T3 (en) 2016-02-01
EP2392337A2 (en) 2011-12-07
HUE030010T2 (en) 2017-04-28
ME02544B (me) 2017-02-20
PL2392336T3 (pl) 2016-12-30
EP1890705A1 (en) 2008-02-27
WO2006119803A1 (en) 2006-11-16
DK2392337T3 (en) 2015-09-28
LT2392336T (lt) 2016-10-10
NO340318B1 (no) 2017-03-27
EP2392337B1 (en) 2015-07-29
PT2392335E (pt) 2015-10-06
HRP20150949T1 (hr) 2015-12-04
EA200702336A1 (ru) 2008-04-28
EP2392336A2 (en) 2011-12-07
EP2392335A3 (en) 2011-12-28
ES2561614T3 (es) 2016-02-29
HK1161122A1 (en) 2012-08-24
SI2392335T1 (sl) 2015-10-30
PL1890705T3 (pl) 2016-05-31
PL2392337T3 (pl) 2015-12-31
NO20076405L (no) 2008-02-11
HUE025184T2 (en) 2016-01-28
PT2392336T (pt) 2016-10-04
ME02737B (me) 2015-12-31
EP2392336B1 (en) 2016-06-22
HUE028336T2 (en) 2016-12-28
ES2590333T3 (es) 2016-11-21
EP2392335B1 (en) 2015-06-24
DK2392335T3 (en) 2015-06-29
ME02256B (me) 2015-12-31
ES2547127T3 (es) 2015-10-01
CY1116840T1 (el) 2017-03-15
RS54140B1 (en) 2015-12-31
CY1117174T1 (el) 2017-04-05
RS54185B1 (en) 2015-12-31
AU2005331734B2 (en) 2012-04-19
DK2392336T3 (en) 2016-09-05
HUE025409T2 (en) 2016-02-29
CY1117959T1 (el) 2017-05-17
SI1890705T1 (sl) 2016-02-29
SI2392337T1 (sl) 2015-10-30
CY1116831T1 (el) 2017-03-15
HRP20151091T1 (hr) 2015-11-06
AU2005331734A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
GB0522715D0 (en) New use
GB0512940D0 (en) Compounds and their use
IL185757A0 (en) Methods of decreasing calcifcation
GB0505954D0 (en) Novel use
GB0520743D0 (en) Compounds and their use
HK1161122A1 (en) Use of 24-norudca 24-norudca
GB0520176D0 (en) Use
GB0511190D0 (en) Use
GB0506001D0 (en) Novel use
GB0526552D0 (en) New use
GB0502250D0 (en) Use
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
GB0526032D0 (en) Use
GB0526031D0 (en) Use
EP1846443A4 (en) NEW USE
GB0508924D0 (en) New use
GB0512574D0 (en) Uses of (s)-clenbuterol
GB0510013D0 (en) Interaction of SNEV
IL166318A0 (en) Cortiutuo shape of sigu
GB0507986D0 (en) Use
GB0503949D0 (en) Use
GB0503950D0 (en) Use
GB0507874D0 (en) Use
TWM292330U (en) Improvement of bed-chair structure
TWM291236U (en) Improved structure of bookrack